<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01552824</url>
  </required_header>
  <id_info>
    <org_study_id>0853/11</org_study_id>
    <secondary_id>0853/11</secondary_id>
    <nct_id>NCT01552824</nct_id>
  </id_info>
  <brief_title>Fetal Cystoscopy Versus Vesico-amniotic Shunting in Severe Lower Urinary Tract Obstructions</brief_title>
  <acronym>CYSTUO</acronym>
  <official_title>Randomized Controlled Trial of Fetal Cystoscopy Versus Vesico-amniotic Shunting in Severe Lower Urinary Tract Obstructions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are two options of fetal treatment in cases of severe lower urinary tract obstructions:
      the vesico-amniotic shunting and fetal cystoscopy. There is no study confirming the
      effectiveness of these treatment, specially comparing both techniques. The present study aims
      to investigate the effectiveness of these treatments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives: To evaluate the effectiveness of fetal cystoscopy for the diagnosis and therapy
      of the posterior urethral valves and to compare with the results of vesicoamniotic shunting.

      Outcomes: Accuracy of the prenatal cystoscopic diagnosis of posterior urethral valves,
      neonatal and infant survival (6 and 12 months), as well as normal renal function during the
      same ages.

      Study design: Randomized controlled trial. Methods: Pregnant women whose fetuses have
      isolated and severe lower urinary tract obstruction (LUTO) with (oligohydramnios and severe
      hydronephrosis) will be invited to participate in the present study. Patients will be
      randomized into the fetal cystoscopic group (CYSTO) vs vesico-amniotic shunting (VAS). The
      investigators intend to enroll 30 patients in each group (a total of 60). All patients will
      be followed by fetal ultrasound each 15 days. Besides, these infants will be followed up to
      one year of age. Maternal and obstetrical complications are going to be evaluated as well as
      neonatal and infant survival and the renal function.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perinatal survival rate</measure>
    <time_frame>from fetal period to neonatal perid (up to 28 days after birth)</time_frame>
    <description>The primary outcome is survival from the treatment to the neonatal period (up to 28 days of life). Therefore, the objective is to evaluate the safety and effectiveness of both therapeutic options.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neonatal renal function</measure>
    <time_frame>up to 28 days of life</time_frame>
    <description>Renal function will be evaluated by serum creatine and urinalysis in the neonates, as well as by micturating cystourethrography and postnatal cystoscopy after birth up to 28 days of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival rate at 6 months</measure>
    <time_frame>Up to 6 months of life</time_frame>
    <description>The survival rate up to 6 months of life will be evaluated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function at 6 months of life</measure>
    <time_frame>6 months of life</time_frame>
    <description>Renal function will be evaluated by serum creatinine, need for dialysis and/or renal transplantation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival rate at 1 year of age</measure>
    <time_frame>1 year of age</time_frame>
    <description>The survival rate will be evaluated at 1 year of age.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal function at 1 year of age</measure>
    <time_frame>1 year of age</time_frame>
    <description>Renal function will be evaluated by serum creatinine, need for dialysis and/or renal transplantation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lower Urinary Tract Obstructive Syndrome</condition>
  <arm_group>
    <arm_group_label>Vesico-amniotic shunt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm, patients will be randomly selected to undergo vesico-amniotic shunting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CYSTO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm, all patients will be randomly selected for fetal cystoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CYSTO</intervention_name>
    <description>Fetal cystoscopy will be performed by introducing a 2.2mm sheath with 1.0mm fetoscope into fetal bladder under ultrasound guidance. The fetoscope will be advanced and the posterior urethral valves will be coagulated by ND:YAG laser. If urethra atresia was diagnosed, a vesico-amniotic shunting will be placed. Maternal anesthesia will be conducted by epidural anesthesia and fetal anesthesia will be conducted by injecting fentanyl (15 μg/Kg) and pancuronium (2 mg/Kg) under ultrasound guidance of a 22 gauge needle into fetal arm muscle.</description>
    <arm_group_label>CYSTO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vesico-amniotic shunt</intervention_name>
    <description>In this arm, all patients randomly selected for this treatment will undergo vesico-amniotic shunting under ultrasound guidance. Maternal anesthesia will be conducted by epidural anesthesia and fetal anesthesia will be conducted by injecting fentanyl (15 μg/Kg) and pancuronium (2 mg/Kg) under ultrasound guidance of a 22 gauge needle into fetal arm muscle.</description>
    <arm_group_label>Vesico-amniotic shunt</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  single pregnancy

          -  male fetuses

          -  gestational age dating by ultrasound examination performed before 20 weeks

          -  confirmed severe LUTO (see details before)

          -  severe oligohydramnios (AFI&lt;5.0cm)

          -  no other structural anomalies by complete fetal anatomy ultrasound scan and fetal
             echocardiogram

          -  no abnormal karyotype

          -  'favorable' urine analysis (urinary sodium &lt;100 mEq/L, chloride &lt;90 mEq/L, osmolarity
             &lt;200 mOsm/L) when gestational age &gt;20 weeks

        Exclusion Criteria:

          -  presence of other anomalies diagnosed after fetal intervention

          -  maternal refusal to participate in the present protocol
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodrigo Ruano, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Medicina da Universidade de Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eugenia MA Salustiano, RN</last_name>
    <phone>(5511)2661-6209</phone>
    <email>eugeniaassuncao@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rodrigo Ruano, MD, PhD</last_name>
    <phone>(5511)2661-6209</phone>
    <email>rodrigoruano@usp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Ruano R, Pimenta EJ, Duarte S, Zugaib M. Four-dimensional ultrasonographic imaging of fetal lower urinary tract obstruction and guidance of percutaneous cystoscopy. Ultrasound Obstet Gynecol. 2009 Feb;33(2):250-2. doi: 10.1002/uog.6292.</citation>
    <PMID>19173237</PMID>
  </reference>
  <reference>
    <citation>Ruano R, Duarte S, Bunduki V, Giron AM, Srougi M, Zugaib M. Fetal cystoscopy for severe lower urinary tract obstruction--initial experience of a single center. Prenat Diagn. 2010 Jan;30(1):30-9. doi: 10.1002/pd.2418.</citation>
    <PMID>19967749</PMID>
  </reference>
  <reference>
    <citation>Ruano R, Yoshisaki CT, Salustiano EM, Giron AM, Srougi M, Zugaib M. Early fetal cystoscopy for first-trimester severe megacystis. Ultrasound Obstet Gynecol. 2011 Jun;37(6):696-701. doi: 10.1002/uog.8963.</citation>
    <PMID>21337440</PMID>
  </reference>
  <reference>
    <citation>Morris RK, Ruano R, Kilby MD. Effectiveness of fetal cystoscopy as a diagnostic and therapeutic intervention for lower urinary tract obstruction: a systematic review. Ultrasound Obstet Gynecol. 2011 Jun;37(6):629-37. doi: 10.1002/uog.8981. Epub 2011 May 16. Review.</citation>
    <PMID>21374748</PMID>
  </reference>
  <reference>
    <citation>Ruano R. Fetal surgery for severe lower urinary tract obstruction. Prenat Diagn. 2011 Jul;31(7):667-74. doi: 10.1002/pd.2736. Epub 2011 Mar 17. Review.</citation>
    <PMID>21413041</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2012</study_first_submitted>
  <study_first_submitted_qc>March 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2012</study_first_posted>
  <last_update_submitted>May 9, 2015</last_update_submitted>
  <last_update_submitted_qc>May 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Rodrigo Ruano</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>LUTO</keyword>
  <keyword>posterior urethral valves</keyword>
  <keyword>urethral atresia</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

